Summary
The pharmacokinetics of ftorafur (FT), an antineoplastic agent, has been studied in seven cancer patients by determining concentrations of the unchanged compound in serum after single IV and PO doses of 2 g FT. Serum drug concentrations were determined by a new quantitative thin-layer chromatographic method. After IV administration, the mean half-lives of the distribution phase and elimination phase were 1.0 h and 7.6 h, respectively. Total serum clearance was 69 ml/h·kg and the apparent volume of distribution was 0.66 l/kg. Following PO administration there was a short lag-time, 11 min, before the appearance of FT in peripheral serum, and the maximum concentration in peripheral serum was achieved in 3.2 h. Oral absorption was complete and no significant first-pass metabolism could be observed. FT elimination, measured in serum taken from the portal vein and a peripheral vein, occurred substantially at the same rate after IV and PO administration. In contrast, after the PO dose FT appeared in the portal serum significantly earlier than in the peripheral serum, resulting in a difference of 1.7 h in the time of maximum serum concentration. This indicates fast gastrointestinal absorption of FT but hepatic retention (without metabolism) before the appearance of FT in the peripheral serum.
Similar content being viewed by others
References
Au JL, Sadee W (1980) Activation of ftorafur [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and γ-butyrolactone. Cancer Res 40: 2814
Au JL, Wu AT, Friedman MA, Sadee W (1979) Pharmacokinetics and metabolism of ftorafur in man. Cancer Treat Rep 63:343
Benvenuto JA, Lu K, Loo TL (1977) High-pressure liquid chromatographic analysis of ftorafur and its metabolites in biological fluids. J Chromatogr 134: 219
Benvenuto JA, Lu K, Hall SW, Benjamin RS, Loo TL (1978) Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans. Cancer Res 38: 3867
Cohen AM (1975) The disposition of ftorafur in rats after intravenous administration. Drug Metab Dispos 3: 303
Hills EB, Godefroi VC, O'Leary IA, Burke M, Andrezejewski O, Brukwinski W, Horwitz JP (1977) GLC determination of ftorafur in biological fluids. J Pharm Sci 66: 1497
Hobara N, Watanabe A (1978) Rapid determination of 1-(2-tetrahydrofuryl)-5-fluorouracil in human blood by high-pressure liquid chromatography. J Chromatogr 146: 518
Horwitz JP, McCormick JJ, Philips KD, Maher VM, Otto JR, Kessels D, Zemlicka J (1975) In vitro biological evaluation of the R and S isomer of 1-(tetrahydrofuran-2-yl)-5-fluorouracil. Cancer Res 35: 1301
Marunaka T, Umeno Y, Yoshida K, Nagamachi M, Minami Y, Fujii, S (1980) High-pressure liquid chromatographic determination of ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after oral administration of uracil plus ftorafur. J Pharm Sci 69: 1296
Metzler CM (1969) NONLIN — a computer program for parameter estimation in nonlinear situations. Upjohn, Kalamazoo (Technical Report no 7292/69/7292/005)
Pantarotto C, Fanelli R, Filippeschi S, Facchinetti T, Spreafico F, Salmona M (1979) Quantitative gas-liquid chromatographic determination of ftorafur and 5-fluorouracil in biological specimens. Anal Biochem 97: 232
Sedman AJ, Wagner JG (1974) AUTOAN — a decision-making pharmacokinetic computer program. Publication Distribution Service, Ann Arbor
Smolyanskaya AZ, Tugarinov OA (1972) The biological activity of antitumor antimetabolite ftorafur. Neoplasma 19: 341
Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton
Wu AT, Schwandt HJ, Finn C, Sadee W (1976) Determination of ftorafur and 5-fluorouracil levels in plasma and urine. Res Commun Chem Pathol Pharmacol 14: 89
Wu AT, Au JL, Sadee W (1978) Hydroxylated metabolites of R,S-1-(tetrahydro-2-furany)-5-fluorouracil (ftorafur) in rats and rabbits. Cancer Res 38: 210
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anttila, M.I., Sotaniemi, E.A., Kairaluoma, M.I. et al. Pharmacokinetics of ftorafur after intravenous and oral administration. Cancer Chemother. Pharmacol. 10, 150–153 (1983). https://doi.org/10.1007/BF00255750
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00255750